{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:48:17Z","timestamp":1790189297057,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Danish Council for Independent Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ijcard.2018.12.005","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T11:44:54Z","timestamp":1546429494000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction"],"prefix":"10.1016","volume":"283","author":[{"given":"Hannah Elena","family":"Suhrs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Flintholm","family":"Raft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijcard.2018.12.005_bb0005","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an endocrine society scientific statement","volume":"102","author":"Barrett","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ijcard.2018.12.005_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcard.2018.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/2047487314545280","article-title":"A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: the CUT-IT trial","volume":"22","author":"Pedersen","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.005_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2007.12.087","article-title":"Effect of weight loss on coronary circulation and adiponectin levels in obese women","volume":"134","author":"Coppola","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.orcp.2016.12.005","article-title":"Long-term effects of bariatric surgery on peripheral endothelial function and coronary microvascular function","volume":"11","author":"Tarzia","year":"2017","journal-title":"Obes. Res. Clin. Pract."},{"issue":"8","key":"10.1016\/j.ijcard.2018.12.005_bb0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.numecd.2010.10.004","article-title":"Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function","volume":"22","author":"Nerla","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-015-0206-3","article-title":"Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study","volume":"14","author":"Faber","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.12.005_bb0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"Prescott","year":"2014","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.ijcard.2018.12.005_bb0050","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study","volume":"37","author":"Wadden","year":"2013","journal-title":"Int. J. Obes."},{"issue":"10","key":"10.1016\/j.ijcard.2018.12.005_bb0055","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.2337\/dc13-0354","article-title":"Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ijcard.2018.12.005_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pcad.2014.12.002","article-title":"Regulation of coronary blood flow in health and ischemic heart disease","volume":"57","author":"Duncker","year":"2015","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.005_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1079\/BJN19940150","article-title":"The cardiovascular, metabolic and hormonal changes accompanying acute starvation in men and women","volume":"71","author":"Webber","year":"1994","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2261-13-106","article-title":"Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol","volume":"13","author":"Pedersen","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2015.03.118","article-title":"A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease","volume":"185","author":"Olsen","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.005_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle angina questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.005_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.echo.2014.11.003","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging","volume":"28","author":"Voigt","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.005_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/ejechocard\/jer176","article-title":"Left ventricular hypertrophy reclassification and death: application of the recommendation of the American society of echocardiography\/European association of echocardiography","volume":"13","author":"Barbieri","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"12","key":"10.1016\/j.ijcard.2018.12.005_bb0105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.ijcard.2018.12.005_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.echo.2016.02.011","article-title":"Coronary flow velocity reserve assessed by transthoracic Doppler: the iPOWER study: factors influencing feasibility and quality","volume":"29","author":"Michelsen","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijcard.2016.11.004","article-title":"Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: the iPOWER study","volume":"228","author":"Michelsen","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.12.005_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000479374","article-title":"Peripheral endothelial function and coronary flow velocity reserve are not associated in women with angina and no obstructive coronary artery disease: the iPOWER study","volume":"54","author":"Flintholm Raft","year":"2017","journal-title":"J. Vasc. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2018.12.005_bb0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1475-2840-12-121","article-title":"Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease","volume":"12","author":"Kawata","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"15","key":"10.1016\/j.ijcard.2018.12.005_bb0135","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2018.12.005_bb0140","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ijcard.2018.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2018.12.005_bb0150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jcmg.2012.12.011","article-title":"Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease","volume":"6","author":"Recio-Mayoral","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"6","key":"10.1016\/j.ijcard.2018.12.005_bb0155","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacc.2005.10.062","article-title":"Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function","volume":"47","author":"Schindler","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0b013e328351680f","article-title":"Methods to investigate coronary microvascular function in clinical practice","volume":"14","author":"Lanza","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"7","key":"10.1016\/j.ijcard.2018.12.005_bb0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2337\/dc17-0291","article-title":"Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: areview of principal cardiovascular outcome results of empa-reg outcome, leader, and sustain-6 trials","volume":"40","author":"Kaul","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2018.12.005_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1475-2840-13-49","article-title":"Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study","volume":"13","author":"Rizzo","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"21","key":"10.1016\/j.ijcard.2018.12.005_bb0175","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2018.12.005_bb0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2018.09.002","article-title":"Glucagon-like peptide-1 receptor action in the vasculature","volume":"111","author":"Almutairi","year":"2019","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ijcard.2018.12.005_bb0195","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2337\/dc12-2469","article-title":"Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes","volume":"36","author":"Ceriello","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ijcard.2018.12.005_bb0200","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","article-title":"Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus","volume":"57","author":"Hogan","year":"2014","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ijcard.2018.12.005_bb0205","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ijcard.2018.12.005_bb0210","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"Basu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12933-016-0425-2","article-title":"Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study","volume":"15","author":"Kumarathurai","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2018.12.005_bb0220","article-title":"Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: a double-blind, randomized, placebo-controlled LIVE sub-study","author":"Nielsen","year":"2017","journal-title":"J. Nucl. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2018.12.005_bb0225","doi-asserted-by":"crossref","first-page":"E947","DOI":"10.1152\/ajpendo.00400.2015","article-title":"Exenatide exerts direct protective effects on endothelial cells through the AMPK\/Akt\/eNOS pathway in a GLP-1 receptor-dependent manner","volume":"310","author":"Wei","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijcard.2018.12.005_bb0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0735-1097(93)90058-9","article-title":"Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy","volume":"22","author":"Antony","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"issue":"27","key":"10.1016\/j.ijcard.2018.12.005_bb0235","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/eht085","article-title":"Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines","volume":"34","author":"Quercioli","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2018.12.005_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","article-title":"Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure","volume":"12","author":"Sokos","year":"2006","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2018.12.005_bb0245","doi-asserted-by":"crossref","first-page":"H1096","DOI":"10.1152\/ajpheart.00930.2009","article-title":"Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure","volume":"298","author":"Halbirk","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.ijcard.2018.12.005_bb0250","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jchf.2016.01.008","article-title":"Effects of the novel long-acting GLP-1 agonist, Albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction","volume":"4","author":"Lepore","year":"2016","journal-title":"JACC Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2018.12.005_bb0505","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: arandomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijcard.2018.12.005_bb0510","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2018.12.005_bb0515","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2281.2001.00296.x","article-title":"Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography","volume":"21","author":"Saraste","year":"2001","journal-title":"Clin. Physiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318330043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318330043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:41:11Z","timestamp":1759092071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318330043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"alternative-id":["S0167527318330043"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.005","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}